MIF investment

The MIF Invests in Luminary Therapeutics, KAHR, and Telo Therapeutics to Accelerate Novel Therapies for the Treatment of Multiple Myeloma Norwalk, CT, Dec. 21, 2022 – The Myeloma Investment Fund (MIF), the Multiple Myeloma Research Foundation’s (MMRF) venture philanthropy subsidiary, today announced investments in Luminary Therapeutics, a company using advanced receptor design to improve the depth […]

Servier golden ticket

The 2020 Servier Golden Ticket awards a biotech focus on oncology 24 SEPTEMBER 2020 Servier has awarded the 2020 Servier Golden Ticket* at MBC Biolabs, to Telo Therapeutics, a biotechnology company focusing on working on solutions to treat TERT promoter (TERTp) mutant cancers. The award will help Telo Therapeutics advance the company’s effort in developing […]